Seller record · ithrivemd.com

iThriveMD

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The GLP-1 pages say only that medication is dispensed by a LegitScript-certified facility, and the GHK-Cu page says the cream is compounded in the company's own laboratory. 1 more criterion also fails; see the table below.

At a glance

iThriveMDithrivemd.com

6/8criteria passed
Price
Semaglutide $199 first month (promotional; regular $299 a month)
Sells
compounded semaglutide, compounded tirzepatide, and 8 more
FDA letters
None on file
Visit iThriveMDSee all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A California clinic group with in-person and telehealth care selling compounded semaglutide and tirzepatide, sermorelin, NAD+, PT-141 and GHK-Cu cream, with monthly and prepaid plans priced on each page. It names no filling pharmacy for its GLP-1 medications.

Operating entity iThriveMD PC

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSithrivemd.com/weight-loss/glp-medications/semaglutide-injections, app.ithrivemd.com/membership
S2Prescription gatingPASSithrivemd.com/weight-loss/glp-medications/semaglutide-injections, app.ithrivemd.com/membership
S3Pharmacy identificationFAILithrivemd.com/weight-loss/glp-medications/semaglutide-injections, ithrivemd.com/peptide-therapy/clinic/ghk-cu-cream
S4Compounding disclosurePASSithrivemd.com/weight-loss/glp-medications/semaglutide-injections
S5Analytical documentationFAILithrivemd.com/contact
S6Business addressPASSithrivemd.com/policy/terms-of-use, ithrivemd.com/contact
S7Price disclosurePASSithrivemd.com/weight-loss/glp-medications/semaglutide-injections, ithrivemd.com/weight-loss/glp-medications/tirzepatide-injections, ithrivemd.com/treatment/sermorelin, ithrivemd.com/treatment/nad-therapy
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSEvery program begins with a clinical consultation, and each compounded product is described as provider-prescribed after an individual clinical evaluation.Source: ithrivemd.com/weight-loss/glp-medications/semaglutide-injections, app.ithrivemd.com/membership.
S2PASSEvery order button on the weight loss pages opens a request for a free consultation, and the plan page states that each compounded product is prescribed by a provider after that consult.Source: ithrivemd.com/weight-loss/glp-medications/semaglutide-injections, app.ithrivemd.com/membership.
S3FAILNo filling pharmacy is named. The GLP-1 pages say only that medication is dispensed by a LegitScript-certified facility, and the GHK-Cu page says the cream is compounded in the company's own laboratory.Source: ithrivemd.com/weight-loss/glp-medications/semaglutide-injections, ithrivemd.com/peptide-therapy/clinic/ghk-cu-cream.
S4PASSCompounded drugs have not been reviewed or approved by the FDA for safety or effectiveness, printed in every footer, and each GLP-1 page names its drug as compounded.Source: ithrivemd.com/weight-loss/glp-medications/semaglutide-injections.
S5FAILThird-party tested is a claim with no document behind it. No certificate or lot report is published on the product pages, the contact page or the policies.Source: ithrivemd.com/contact.
S6PASSiThriveMD PC at 285 N El Camino Real, STE 211, Encinitas, CA 92024, printed in the terms for notices and returns, and the same address heads the list of clinic locations on the contact page.Source: ithrivemd.com/policy/terms-of-use, ithrivemd.com/contact.
S7PASSCompounded semaglutide at $199 for the first month, a $100 promotional discount on the regular $299 a month, or $239.20 a month on a 48-week prepaid plan. Compounded tirzepatide at $299 for the first month against a regular $399 a month, and sermorelin and NAD+ at $249 a month.Source: ithrivemd.com/weight-loss/glp-medications/semaglutide-injections, ithrivemd.com/weight-loss/glp-medications/tirzepatide-injections, ithrivemd.com/treatment/sermorelin, ithrivemd.com/treatment/nad-therapy.
S8PASSNo FDA warning letter names iThriveMD or iThriveMD PC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, microdose compounded tirzepatide, sermorelin, NAD+, PT-141, GHK-Cu cream, glutathione, testosterone, bioidentical hormone therapy.

Other sellers of the same products

Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+Who sells glutathioneWho sells PT-141Who sells GHK-Cu

Unpaid link. iThriveMD does not pay the site, and nothing is earned when it is used. Funding.

Visit iThriveMD

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.